Oppenheimer & Co Inc’s Bristol-Myers Squibb Co Position
Does Oppenheimer & Co Inc own Bristol-Myers Squibb Co (BMY)? Yes — 254.1K shares worth $15M (+0.19% of its 13F portfolio) as of Q1 2026, up from 238.6K shares the prior filed quarter.
Position Value
$15M
Q1 2026
Shares
254.1K
% of Portfolio
+0.19%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 254.1K | $15M | +0.19% |
| Q4 2025 | 238.6K | $13M | +0.18% |
| Q3 2025 | 245.8K | $11M | +0.14% |
| Q2 2025 | 243.7K | $11M | +0.15% |
| Q1 2025 | 242.5K | $15M | +0.22% |
| Q4 2024 | 215.2K | $12M | +0.18% |
| Q3 2024 | 234.2K | $12M | +0.18% |
| Q2 2024 | 203.3K | $8M | +0.13% |
| Q1 2024 | 218.8K | $12M | +0.20% |
| Q4 2023 | 192.3K | $10M | +0.18% |
| Q3 2023 | 207.6K | $12M | +0.25% |
| Q2 2023 | 232.2K | $15M | +0.30% |
| Q1 2023 | 235.0K | $16M | +0.35% |
| Q4 2022 | 233.2K | $17M | +0.38% |
| Q3 2022 | 243.7K | $17M | +0.41% |
| Q2 2022 | 263.8K | $20M | +0.44% |
| Q1 2022 | 278.7K | $20M | +0.37% |
| Q4 2021 | 268.9K | $17M | +0.29% |
| Q3 2021 | 294.1K | $17M | +0.33% |
| Q2 2021 | 281.0K | $19M | +0.34% |
| Q1 2021 | 372.6K | $24M | +0.47% |
| Q4 2020 | 385.9K | $24M | +0.51% |
| Q3 2020 | 372.5K | $22M | +0.56% |
| Q2 2020 | 365.8K | $22M | +0.56% |
| Q1 2020 | 378.1K | $21M | +0.64% |
| Q4 2019 | 364.1K | $23M | +0.58% |
| Q3 2019 | 301.1K | $15M | +0.42% |
| Q2 2019 | 304.3K | $14M | +0.37% |
| Q1 2019 | 298.0K | $14M | +0.38% |
| Q4 2018 | 306.2K | $16M | +0.50% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer & Co Inc’s full portfolio or all institutional holders of BMY.